Assignee
AFFERENT PHARMACEUTICALS INC
US·13 granted patents·3 pending applications·26 citations·filing 2014–2024
Top patents by PatentIndex Score
16 records- 0187US9284279B2Substituted pyrimidines for treatment of acute cough, chronic cough and urge to coughAFFERENT PHARMACEUTICALS INC·Filed 2014·Granted Mar 15, 2016·13 cites·20 claims
- 0283US10822311B2Pyrimidines and variants thereof, and uses thereforAFFERENT PHARMACEUTICALS INC·Filed 2017·Granted Nov 3, 2020·3 cites·16 claims
- 0381US10662162B2Pyrimidines and variants thereof, and uses thereforAFFERENT PHARMACEUTICALS INC·Filed 2017·Granted May 26, 2020·2 cites·8 claims
- 0479US10676444B2Crystalline salts and polymorphs of a P2X3 antagonistAFFERENT PHARMACEUTICALS INC·Filed 2017·Granted Jun 9, 2020·1 cites·20 claims
- 0577US10206922B2Substituted pyrimidines for treatment of chronic cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute coughAFFERENT PHARMACEUTICALS INC·Filed 2017·Granted Feb 19, 2019·2 cites·20 claims
- 0676US9724346B2Substituted pyrimidines for treatment of a cough selected from chronic pathological cough, sub-acute pathological cough, acute pathological cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute coughAFFERENT PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2017·2 cites·15 claims
- 0774US10195198B2Methods and compositions for treating diseases and conditionsAFFERENT PHARMACEUTICALS INC·Filed 2015·Granted Feb 5, 2019·2 cites·8 claims
- 0872US10543211B2Methods and compositions for treating diseases and conditionsAFFERENT PHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·1 cites·20 claims
- 0968US2024285620A1Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of coughAFFERENT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1066US11230533B2Crystalline salts and polymorphs of a P2X3 antagonistAFFERENT PHARMACEUTICALS INC·Filed 2020·Granted Jan 25, 2022·0 cites·19 claims
- 1166US2020108065A1Methods and compositions for treating diseases and conditionsAFFERENT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1264US11591315B2Substituted pyrazole-pyrimidines, variants thereof, and uses thereforeAFFERENT PHARMACEUTICALS INC·Filed 2021·Granted Feb 28, 2023·0 cites·12 claims
- 1362US2022143015A1Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of coughAFFERENT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1460US11230532B2Pyrimidines and variants thereof, and uses thereforAFFERENT PHARMACEUTICALS INC·Filed 2020·Granted Jan 25, 2022·0 cites·12 claims
- 1557US10988460B2Substituted pyrazole-pyrimidines, variants thereof, and uses thereforeAFFERENT PHARMACEUTICALS INC·Filed 2017·Granted Apr 27, 2021·0 cites·18 claims
- 1646US11260056B2Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in the treatment of coughAFFERENT PHARMACEUTICALS INC·Filed 2016·Granted Mar 1, 2022·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when AFFERENT PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →